ING Group’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-5,000
| Closed | -$549K | – | 807 |
|
|
2018
Q2 | $549K | Buy |
+5,000
| New | +$549K | 0.01% | 434 |
|
|
2017
Q3 | – | Sell |
-11,340
| Closed | -$1.17M | – | 855 |
|
|
2017
Q2 | $1.17M | Sell |
11,340
-15,708
| -58% | -$1.62M | 0.02% | 294 |
|
|
2017
Q1 | $2.64M | Hold |
27,048
| – | – | 0.05% | 212 |
|
|
2016
Q4 | $2.41M | Buy |
27,048
+4,800
| +22% | +$427K | 0.05% | 202 |
|
|
2016
Q3 | $2.12M | Sell |
22,248
-1,200
| -5% | -$114K | 0.03% | 212 |
|
|
2016
Q2 | $2.01M | Buy |
23,448
+17,694
| +308% | +$1.52M | 0.03% | 195 |
|
|
2016
Q1 | $500K | Sell |
5,754
-8,994
| -61% | -$782K | 0.01% | 377 |
|
|
2015
Q4 | $1.67M | Sell |
14,748
-21,300
| -59% | -$2.4M | 0.01% | 441 |
|
|
2015
Q3 | $3.63M | Hold |
36,048
| – | – | 0.03% | 319 |
|
|
2015
Q2 | $4.44M | Sell |
36,048
-6,000
| -14% | -$739K | 0.02% | 373 |
|
|
2015
Q1 | $4.81M | Hold |
42,048
| – | – | 0.02% | 412 |
|
|
2014
Q4 | $4.25M | Buy |
42,048
+27,048
| +180% | +$2.74M | 0.02% | 405 |
|
|
2014
Q3 | $1.37M | Hold |
15,000
| – | – | 0.01% | 500 |
|
|
2014
Q2 | $1.28M | Sell |
15,000
-31,533
| -68% | -$2.7M | 0.01% | 511 |
|
|
2014
Q1 | $3.67M | Buy |
46,533
+3,678
| +9% | +$290K | 0.02% | 410 |
|
|
2013
Q4 | $3.24M | Buy |
42,855
+20,853
| +95% | +$1.58M | 0.02% | 414 |
|
|
2013
Q3 | $1.54M | Buy |
22,002
+4,002
| +22% | +$280K | 0.01% | 520 |
|
|
2013
Q2 | $1.05M | Buy |
+18,000
| New | +$1.05M | 0.01% | 544 |
|